Results 261 to 270 of about 294,683 (378)
Bilateral internal jugular vein (BIJV) sampling during surgery for primary hyperparathyroidism (PHPT) - scoping review of evidence and search for an optimal definition for lateralisation. [PDF]
Prakash V +2 more
europepmc +1 more source
Parathyroid hormone: anabolic and catabolic actions on the skeleton.
B. C. Silva, J. Bilezikian
semanticscholar +1 more source
Burosumab in Unidentifiable Tumor‐Induced Osteomalacia
ABSTRACT Tumor‐induced osteomalacia (TIO) can be challenging due to underlying tumors being either unresectable or unidentifiable. Burosumab, an anti‐FGF23 monoclonal antibody, has been proven to be effective in treating TIO but is currently not subsidized for this indication in Australia.
Yi Shan Der +5 more
wiley +1 more source
Large atypical parathyroid tumor mimicking metastatic papillary thyroid carcinoma: a case report. [PDF]
Wang A +7 more
europepmc +1 more source
Detecting the Near Infrared Autofluorescence of the Human Parathyroid
Carmen C. Solórzano +3 more
openalex +2 more sources
Genetics of parathyroid tumours
R. Thakker
semanticscholar +1 more source
Incidental Diagnosis of Fahr's Disease Following Severe Traumatic Brain Injury: A Case Report
ABSTRACT Fahr's disease is a rare idiopathic neurodegenerative disorder characterized by symmetrical calcifications in the basal ganglia and cerebellar dentate nuclei. Although it may present with diverse neuropsychiatric symptoms, a significant number of cases remain asymptomatic and are only identified incidentally through neuroimaging performed for ...
Hadi Ebrahimi +5 more
wiley +1 more source
Novel Genetic Findings in Stuve‐Wiedemann Syndrome: A Case Report and Review of Literature
ABSTRACT Stuve‐Wiedemann Syndrome (SWS) is a rare autosomal recessive condition, first reported in 1971 by Stuve and Wiedemann. It is associated with pathogenic or likely pathogenic homozygous or compound heterozygous variants in the Leukemia Inhibitory Factor Receptor (LIFR) gene.
Khalid Hamasalih Hamasharef +4 more
wiley +1 more source

